Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Thursday, April 10, 2025.
Stock Region Penny Picks Watchlist Newsletter - Thursday, April 10, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information provided in this newsletter is for educational and informational purposes only. It should not be considered as financial advice or a recommendation to buy, sell, or hold any securities. Always conduct your own research or consult with a financial advisor before making any investment decisions.
$KTTA - Pasithea Therapeutics
Pasithea Therapeutics announced a positive safety review committee (SRC) recommendation for its ongoing Phase 1 clinical trial of PAS-004 in advanced cancer. This update marks a significant step forward in its drug development process.
$BCRX - BioCryst Pharmaceuticals
Needham has reiterated its "Buy" rating on BioCryst Pharmaceuticals, maintaining a price target of $15. With the stock currently trading at $6.76, this represents substantial potential upside based on the analyst's evaluation.
$BCLI - BrainStorm Cell Therapeutics
BrainStorm Cell Therapeutics submitted an IND amendment to the FDA for a Phase 3b trial of NurOwn, a treatment targeting Amyotrophic Lateral Sclerosis (ALS). Investors will want to monitor developments closely, as this decision could be pivotal for the company's future.
$ELAB - Northstrive Biosciences (Subsidiary of PMGC Holdings)
Northstrive Biosciences has entered into a development and licensing agreement with Yuva Biosciences. The collaboration aims to explore treatments for obesity, Type 2 diabetes, and other cardiometabolic conditions, tapping into a growing healthcare market.
$PRFX - PainReform Ltd.
PainReform announced its expansion into the Smart Energy Management (SEM) sector through its acquisition of DeepSolar. This move positions PainReform within the renewable energy space, leveraging AI-driven software to optimize solar energy usage in both residential and utility-scale applications.
$CDT - CoData Technologies
The Board of Directors of CoData Technologies has approved a $1 million share repurchase program. The company believes its stock is undervalued, signaling confidence in its long-term potential.
$ATHR - Atherix IPO Update
The IPO for Atherix has been halted at $7.34. Atherix describes itself as a financial technology platform integrating advanced AI tools to provide both retail and institutional traders with actionable insights. Watch for further announcements regarding its trading debut.
$VERO - Venus Concept
Venus Concept has closed a $1.1 million registered direct offering at-the-market under Nasdaq rules. This funding round provides additional capital to support its business initiatives.
Thank you for subscribing to Stock Region Newsletter! Stay informed, trade smart.
Disclaimer: The updates included herein are based on publicly available information and should not be relied upon for investment decisions. Stock Region is not responsible for any losses arising from trades placed based on this content. Always assess risks and opportunities with due diligence.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net